Table 1 Patient demographics and baseline characteristics
|  | TGC (n = 14) | GC (n = 17) | p value |
|---|---|---|---|
Age, years | |||
 < 65 | 6 (42.9) | 7 (41.2) | 0.93 |
 ≥ 65 | 8 (57.1) | 10 (58.8) |  |
Gender | |||
Male | 10 (71.4) | 12 (70.6) | 0.96 |
Female | 4 (28.6) | 5 (29.4) | Â |
Tobacco use | |||
Never | 5 (35.7) | 7 (41.2) | 0.77 |
Current or former | 9 (64.3) | 10 (58.8) | Â |
ECOG status | |||
0 | 7 (50) | 9 (52.9) | 0.88 |
1 | 7 (50) | 8 (47.1) | Â |
Disease status | |||
Locally advanced | 4 (28.6) | 6 (35.3) | 0.70 |
Metastatic | 10 (71.4) | 11 (64.7) | Â |
Site of metastatic disease | |||
Lymph nodes only | 2 (14.3) | 2 (11.8) | 0.86 |
Viscerala ± lymph nodes | 3 (21.4) | 3 (17.6) |  |
Multiple metastatic sites | 5 (35.7) | 6 (35.3) | Â |
PD-L1 expression | |||
TC < 50% and IC <  50% | 6 (42.9) | 8 (47.1) | 0.73 |
TC ≥ 50% or IC ≥ 50% | 2 (14.3) | 3 (17.6) |  |
Unknown | 6 (42.9) | 6 (35.3) | Â |